Brigatinib Tablet is a cancer medicine that is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) who have been treated before with a cancer medicine called crizotinib.
Brigatinib Tablet Market contains market size and forecasts of Brigatinib Tablet in global, including the following market information:
- Global Brigatinib Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Brigatinib Tablet Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Brigatinib Tablet companies in 2021 (%)
The global Brigatinib Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
30mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brigatinib Tablet include ARIAD Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Brigatinib Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brigatinib Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Brigatinib Tablet Market Segment Percentages, by Type, 2021 (%)
Global Brigatinib Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Brigatinib Tablet Market Segment Percentages, by Application, 2021 (%)
Global Brigatinib Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Brigatinib Tablet Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Brigatinib Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Brigatinib Tablet revenues share in global market, 2021 (%)
- Key companies Brigatinib Tablet sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Brigatinib Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Industry Market Size
